Recording intelligenceAI-generated brief · check the source for context

Floss-Based Vaccination and IgA Protection

1:10:50 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Steph Langell presents a Nature Biomedical Engineering paper, first author Rohan Ingrill and last author Harvinder Singh Gill of Texas Tech, NC State and UNC Chapel Hill, in which vaccine antigen is coated on flat floss tape and used to floss the two front teeth of a mouse, targeting the permeable junctional epithelium at the base of the gingival sulcus.4:50
  • With a CPG adjuvant the floss raised serum and mucosal responses and protected mice in an influenza challenge better than an intranasal vaccine, though salivary IgA barely moved, suggesting antigen is mainly crossing to the systemic compartment through the microtrauma of flossing.20:56
  • In healthy volunteers aged 18 to 50 using a commercial floss pick coated with blue food dye, 59% of the 100-microgram coating reached the gingival sulcus and 56% of participants flossed between 2 and 11 times (five passes most common), while 67% said they would be more inclined to take flu or coronavirus vaccines this way; the hosts flag user error and the paper's line that it only works for indiv22:55
  • Vincent Racaniello then covers a PNAS paper from Brett Finley's group at University of British Columbia, first author Catherine Donald, using the Canadian CHILD cohort of 300 mother-infant pairs to ask which infant gut bacteria human milk secretory IgA (one to eight grams per liter) targets.27:32
  • E. ramosum was the only species negatively associated with secretory IgA targeting, and IgA purified from 20 high-binding milk samples blocked its adherence to intestinal epithelial cells and the Th17-driving cytokine programme, while heat-denatured or low-binding IgA did not and the bacterium does not adhere in mice at all, which limits mechanistic work.47:49

Brief overview

Floss-delivered vaccine protects mice, and human milk IgA limits a Th17-inducing gut bacterium in infants.

  1. Floss can carry vaccine antigen into the gum creviceAntigen-coated flat floss tape delivered 59% of a 100-microgram dose to the human gingival sulcus and protected mice against influenza challenge.
  2. The route looks systemic, not mucosalSalivary IgA was not raised, so the hosts read the effect as antigen crossing to the blood through flossing microtrauma rather than true mucosal immunisation.
  3. Milk IgA restrains one Th17-inducing infant gut microbeSecretory IgA from high-binding milk blocked E. ramosum adherence to gut epithelial cells and the IL-17 pathway it switches on.

Questions this recording answers

10 questions, each answered where it is said
What is the floss-based vaccine described in the paper?

Vaccine antigen is coated onto dental floss thread and used to floss the two front teeth of a mouse. Braided thread trapped antigen in its gaps, so the group used a flat tape thread for even delivery. They bought the floss at CVS, and the mice were anesthetized.

Answered around 14:13
Why aim a vaccine at the gingival sulcus?

At the base of the gingival sulcus sits junctional epithelium that is non-keratinized, so it has high permeability and an abundant amount of immune cells. That natural leakiness allows antigen entry into the blood and possibly the mucosal tissues there. The lead author learned about the sulcus reading off topic.

Answered around 14:36
Did the floss vaccine protect mice against influenza?

In a challenge model against influenza they do see protection, and enhanced protection over an intranasal vaccine. The mouse influenza model can be terminal, so this is probably systemic protection through increased systemic IgG. They did not do transmission studies, and the floss did not appear to raise salivary IgA.

Answered around 20:56
How much antigen reached the gums in the human volunteers?

Healthy volunteers aged 18 to 50 used a commercially available floss pick coated with blue food dye. 59% of the 100-microgram coating was delivered to the gingival sulcus, with some still remaining on the floss. 56% of participants flossed between 2 and 11 times, five passes being most common.

Answered around 22:55
Would people accept a vaccine delivered by dental floss?

In surveys taken afterwards, 67% of the people said they would be more inclined to receive flu or coronavirus vaccines by floss. The hosts thought it could reduce anti-vax sentiment: easier than a pill, which is hard for kids, and the easiest option compared with an injection.

Answered around 24:10
Who could not use a floss-delivered vaccine?

The discussion states it can only be used for individuals with teeth, which the hosts laughed at. That leaves out children up to about six months, who have no teeth, and older people with dentures rather than teeth, eliminating many elderly who need flu, RSV and COVID vaccines.

Answered around 25:39
Where does the secretory IgA in breast milk come from?

It is made by plasma cells that originate in the mother's gut, so there is a gut mammary gland axis alongside the brain-gut axis. Those antibodies target the gut microbiota in the mother and in the baby, because the same microbes colonize mom and the infant in the same environment.

Answered around 29:59
Which infant gut bacterium does milk IgA appear to control?

Metagenomics of the baby fecal samples showed E. ramosum was the only species in the infant gut with a significant negative association with secretory IgA targeting. The group therefore focused on it, proposing that secretory IgA limits this species in the human gut, and then tested that hypothesis.

Answered around 39:33
How does milk secretory IgA limit E. ramosum?

E. ramosum adheres hard to human CACO2 intestinal epithelial cells and induces cytoskeletal and actin rearrangement. Secretory IgA from 20 human milk samples with very high binding reduced that adherence. Heat-denatured antibody did not, and IgA purified from 20 samples with low binding capacity also failed to limit adherence.

Answered around 47:49
Why can't E. ramosum be studied in mice?

E. ramosum did not adhere to murine intestinal cells, because mice do not carry this bacterium. Germ-free mice infected with it made no Th17 response in small intestine or colon, and specific-pathogen-free mice depleted with vancomycin and then fed the bacterium also failed to induce a Th17 response.

Answered around 50:39
Key Quote

“You cannot do intense Psycom and have a lab.”

— Vincent Racaniello, Floss-Based Vaccination and IgA Protection, at 3:40▶ listen at 3:40
Key Quote

“how do you set up a oral vaccine or a mucosal vaccine and make sure that it doesn't lead to a tolerance response?”

— Brianne Barker, Floss-Based Vaccination and IgA Protection, at 9:22▶ listen at 9:22
Key Quote

“I think there's some significant challenges with actually implementing this, but I really love the creativity of it.”

— Cindy Leifer, Floss-Based Vaccination and IgA Protection, at 25:05▶ listen at 25:05
Key Quote

“It can only be used for individuals with teeth.”

— Steph Langell, Floss-Based Vaccination and IgA Protection, at 25:39▶ listen at 25:39

Cite this

“Floss-Based Vaccination and IgA Protection.” https://traffic.libsyn.com/secure/immune/Immune096.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/floss-based-vaccination-and-iga-protection.html.

Report this page
What is wrong with this page?